
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors
Sahil Hussain, Mohd Mursal, Garima Verma, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176484-176484
Closed Access | Times Cited: 11
Sahil Hussain, Mohd Mursal, Garima Verma, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176484-176484
Closed Access | Times Cited: 11
Showing 11 citing articles:
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 5
Mohammed Hawash
Cells (2024) Vol. 13, Iss. 19, pp. 1656-1656
Open Access | Times Cited: 5
Encrypting Cancer’s Morse Code: The Synergistic Power of CD47-SIRP<i>α</i> Blockade and Tyrosine Kinase Inhibition
Mahamud Hirsi, Yahya Lahrach, Abdirahman Mohamud Abdirahman, et al.
International Journal of Clinical Medicine (2025) Vol. 16, Iss. 02, pp. 135-153
Open Access
Mahamud Hirsi, Yahya Lahrach, Abdirahman Mohamud Abdirahman, et al.
International Journal of Clinical Medicine (2025) Vol. 16, Iss. 02, pp. 135-153
Open Access
Mps1 kinase functions in mitotic spindle assembly and error correction
Víctor M. Bolaños-García
Trends in Biochemical Sciences (2025)
Open Access
Víctor M. Bolaños-García
Trends in Biochemical Sciences (2025)
Open Access
Targeting TGF-β: a promising strategy for cancer therapy
Himani Rathi, Charanjit Kaur, Rajesh Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Himani Rathi, Charanjit Kaur, Rajesh Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators
Kinga Tóth, Zsuzsanna Gaál
Cancers (2025) Vol. 17, Iss. 8, pp. 1282-1282
Open Access
Kinga Tóth, Zsuzsanna Gaál
Cancers (2025) Vol. 17, Iss. 8, pp. 1282-1282
Open Access
Layer-by-layer fabrication of covalent organic frameworks on stainless steel needles as solid-phase microextraction probe coupled with electrospray ionization mass spectrometry for enrichment and determination of tyrosine kinase inhibitors in biosamples
Heming Li, Xinye Shi, Hang Su, et al.
Journal of Chromatography A (2024) Vol. 1733, pp. 465276-465276
Closed Access | Times Cited: 3
Heming Li, Xinye Shi, Hang Su, et al.
Journal of Chromatography A (2024) Vol. 1733, pp. 465276-465276
Closed Access | Times Cited: 3
Analytical quality by design-compliant development of quantitative 1H- and 19F-nuclear magnetic resonance methods for the analytical evaluation of the anti-cancer drug, sorafenib
Marwa H. Hassan, Reham A. I. Abou‐Elkhair, Abdalla E. A. Hassan, et al.
Microchemical Journal (2024), pp. 112544-112544
Closed Access | Times Cited: 3
Marwa H. Hassan, Reham A. I. Abou‐Elkhair, Abdalla E. A. Hassan, et al.
Microchemical Journal (2024), pp. 112544-112544
Closed Access | Times Cited: 3
Synthesis and anti-tumor activity of new benzofuran-based chalcone derivatives as potent VEGFR-2 inhibitors
Chunfei Zhang, Yixin Liu, Xiao Zhang, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Chunfei Zhang, Yixin Liu, Xiao Zhang, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Emerging Techniques in Cancer Therapy: Precision Targeting for Improved Outcomes
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1446-1448
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1446-1448
Open Access
Star wars against leukemia: attacking the clones
Monika M. Toma, Tomasz Skórski
Leukemia (2024)
Open Access
Monika M. Toma, Tomasz Skórski
Leukemia (2024)
Open Access
Novel TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 1, pp. 8-9
Closed Access
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 16, Iss. 1, pp. 8-9
Closed Access